Citius Pharmaceuticals, Inc. - 8-K Filing

Citius Oncology reports positive health-related quality of life data for LYMPHIR in pivotal Study 302 presented at EORTC-CLTG 2026 Annual Meeting (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $CTXR

Read the full article at SEC EDGAR

More Regulatory news